FIELD: medicine.
SUBSTANCE: activated-potentiated form of antibodies to one or several cytokines, selected from interferon alpha, interferon gamma and tumour necrosis factor, in combination with activated-potentiated form of antibodies to receptor of CD4 or CD8 lymphocytes, or to their combination, is introduced into organism.
EFFECT: increased efficiency of treating bacterial or viral infections due to activation of humoral and cellular immunity.
23 cl, 12 ex, 19 tbl
Authors
Dates
2016-03-10—Published
2011-07-04—Filed